Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00280644
Status:
COMPLETED
Last Update Posted:
2011-01-11
First Post:
2006-01-19
Brief Title:
Leflunomide in Rheumatoid Arthritis
Sponsor:
Sanofi
Organization:
Sanofi
Study Overview
Official Title:
Efficacy of Leflunomide on Joint Inflammation and Destruction of Joint Integrity in Active Rheumatoid Arthritis RA Patients
Status:
COMPLETED
Status Verified Date:
2011-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study objectives
To provide more insight on the modulation of inflammation and matrix degrading factors in serum and urine by leflunomide in early active patients with RA and to validate the sensitivity of DEMRI Dynamic Enhanced Magnetic Resonance Imaging in detecting inflammatory changes in active RA in response to treatment with leflunomide
Effect of leflunomide therapy on physical function improvement and Quality of life
To provide more insight on the modulation of inflammation and matrix degrading factors in serum and urine by leflunomide in early active patients with RA and to validate the sensitivity of DEMRI Dynamic Enhanced Magnetic Resonance Imaging in detecting inflammatory changes in active RA in response to treatment with leflunomide
Effect of leflunomide therapy on physical function improvement and Quality of life
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None